NHS: Drugs

(asked on 14th December 2015) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, pursuant to the Answer of 23 November 2015 to Question 16399, what discussions he has had with the Accelerated Access Review team on biosimilars medicines; and whether he has been given assurance that the final report will make specific recommendations on their use.


Answered by
George Freeman Portrait
George Freeman
This question was answered on 18th December 2015

In accordance with the terms of reference the Accelerated Access Review is not excluding any particular type or class of medicine, but is creating a framework through which to accelerate access for National Health Service patients to innovative health technologies including biosimilar medicines where appropriate.

Reticulating Splines